K. Yu et al., DIFFERENTIAL ACTIVATION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS BY EICOSANOIDS, The Journal of biological chemistry, 270(41), 1995, pp. 23975-23983
Peroxisome proliferator-activated receptors (PPARs) are nuclear hormon
e receptors that regulate gene transcription in response to peroxisome
proliferators and fatty acids. PPARs also play an important role in t
he regulation of adipocyte differentiation. It is unclear, however, wh
at naturally occurring compounds activate each of the PPAR subtypes. T
o address this issue, a screening assay was established using heterolo
gous fusions of the bacterial tetracycline repressor to several member
s of the peroxisome proliferator-activated receptor (PPAR) family. Thi
s assay was employed to compare the activation of PPAR family members
by known PPAR activators including peroxisome proliferators and fatty
acids. Interestingly, the activation of PPARs by fatty acids was parti
ally inhibited by the cyclooxygenase inhibitor indomethacin, which pre
vents prostaglandin synthesis. Indeed, prostaglandins PGA1 and 2, PGD1
and 2, and PGJ2-activated PPARs, while a number of other prostaglandi
ns had no effect. We also screened a variety of hydroxyeicosatetraenoi
c acids (HETEs) for the ability to activate PPARs. 8(S)-HETE, but not
other (S)-HETEs, was a strong activator of PPAR alpha. Remarkably, PPA
R activation by 8(S)-HETE was stereoselective. In addition, 8(S)-HETE
was able to induce differentiation of 3T3-L1 preadipocytes. These resu
lts indicate that PPARs are differentially activated by naturally occu
rring eicosanoids and related molecules.